Evidence map›Paper›PMID 37563311›Full record

ArticleNature immunology2023

Runx factors launch T cell and innate lymphoid programs via direct and gene network-based mechanisms.

Boyoung Shin, Wen Zhou, Jue Wang, Fan Gao, Ellen V Rothenberg

Erratum issuedOpen access · greenAbstract read
In one paragraph

Article in Nature immunology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
4.2field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Transcriptional network dynamics in early T cell development.The Journal of experimental medicine · 2024
    Review
  18. Article
  19. T-cell commitment inheritance-an agent-based multi-scale model.NPJ systems biology and applications · 2024
    Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Boyoung ShinDivision of Biology and Biological Engineering, California Institute of Technology, Pasadena, CA, USA.
Wen ZhouDivision of Biology and Biological Engineering, California Institute of Technology, Pasadena, CA, USA.
Jue WangDivision of Biology and Biological Engineering, California Institute of Technology, Pasadena, CA, USA.ORCID http://orcid.org/0000-0002-5623-0994
Fan GaoDivision of Biology and Biological Engineering, California Institute of Technology, Pasadena, CA, USA.
Ellen V RothenbergDivision of Biology and Biological Engineering, California Institute of Technology, Pasadena, CA, USA. evroth@its.caltech.edu.ORCID http://orcid.org/0000-0002-3901-347X
California Institute of Technology · US

Funding

Molecular and Cellular Mechanisms in CancerT32CA108462 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI GOGA, ANDREI · 2004 to 2024
$10.4M
System dynamics and gene network architecture of early T-cell developmentR01HD100039 · NICHD · CALIFORNIA INSTITUTE OF TECHNOLOGY · PI ELLEN V. ROTHENBERG · 2019 to 2026
$4.1M
FUNCTIONAL GENOMICS AND MECHANISM OF BCL11B ACTION IN LYMPHOCYTE COMMITMENTR01AI135200 · NIAID · CALIFORNIA INSTITUTE OF TECHNOLOGY · PI ROTHENBERG, ELLEN V. · 2018 to 2022
$3.2M
Kinetic modeling and single-cell molecular mechanisms of early T-cell commitmentR01HL119102 · NHLBI · CALIFORNIA INSTITUTE OF TECHNOLOGY · PI PETERSON, CARSTEN, ROTHENBERG, ELLEN V. · 2014 to 2018
$3.0M
The role of ATP13A5 ATPase in determining blood-brain pericyte functionsRF1NS135617 · NINDS · UNIVERSITY OF SOUTHERN CALIFORNIA · PI ZHAO, ZHEN · 2023 to 2023
$2.4M
A TIMEM252-dependent Microvascular Endophenotype in Alzheimer’s DiseaseRF1NS122060 · NINDS · UNIVERSITY OF SOUTHERN CALIFORNIA · PI ZHAO, ZHEN · 2021 to 2021
$2.3M
A TIMEM252-dependent Microvascular Endophenotype in Alzheimer’s DiseaseR01NS122060 · NINDS · UNIVERSITY OF SOUTHERN CALIFORNIA · PI ZHAO, ZHEN · 2024 to 2025
$1.5M
Allylsilane Annulation Strategy for Diversity SynthesisF32CA094588 · NCI · HARVARD UNIVERSITY · PI FRANZ, ANNALIESE K · 2002 to 2004
$125k
NCI NIH HHS F32 CA094588NCI NIH HHS T32 CA108462NHLBI NIH HHS R01 HL119102NIAID NIH HHS R01 AI135200NICHD NIH HHS R01 HD100039NINDS NIH HHS R01 NS122060NINDS NIH HHS RF1 NS122060NINDS NIH HHS RF1 NS135617
6 · The paper itself

Abstract

Runx factors are essential for lineage specification of various hematopoietic cells, including T lymphocytes. However, they regulate context-specific genes and occupy distinct genomic regions in different cell types. Here, we show that dynamic Runx binding shifts in mouse early T cell development are mostly not restricted by local chromatin state but regulated by Runx dosage and functional partners. Runx cofactors compete to recruit a limited pool of Runx factors in early T progenitor cells, and a modest increase in Runx protein availability at pre-commitment stages causes premature Runx occupancy at post-commitment binding sites. This increased Runx factor availability results in striking T cell lineage developmental acceleration by selectively activating T cell-identity and innate lymphoid cell programs. These programs are collectively regulated by Runx together with other, Runx-induced transcription factors that co-occupy Runx-target genes and propagate gene network changes.

Indexed as

Gene Regulatory NetworksT-LymphocytesAnimalsCell DifferentiationCore Binding Factor alpha SubunitsImmunity, InnateLymphocytesMiceCore Binding Factor alpha Subunits

Identifiers

PMID37563311
PMCPMC10673614
OpenAlexW4385737357

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.